The customer stated that they received an erroneous results for one severely lipemic patient sample tested for trigl triglycerides (trig) on a cobas 8000 c 702 module (c702).The erroneous result was not reported outside of the laboratory.The sample initially resulted as 173.3 mg/dl.The sample was automatically diluted 1:50 and repeated on a different analyzer, resulting as 6863.7 mg/dl.No adverse events were alleged to have occurred with the patient.The c702 analyzer serial number was asked for, but not provided.The reaction monitor of the first result showed a strong decrease in absorbance due to oxygen depletion during the assay reaction.It was confirmed that the customer was not using the most current version of the application parameters.In the most current test application version, the prozone check limit value was reduced in order to allow flagging of incorrect low triglyceride results of lipemic patient samples on the c702 analyzer.Upon review of calibration data, the last valid 2 point calibration was performed on (b)(6) 2017.From (b)(6) 2017 to (b)(6) 2017, successful blank calibrations were performed.Data was provided for one level of quality control and this was within range on the day of the event.Upon review of the alarm trace, several abnormal aspiration and sample short alarms could be observed from (b)(6) 2017 to (b)(6) 2017.The root cause is most likely related to the test application not being updated to the most current version.Based on the alarms received, a pre-analytic sample handling issue may also be a possible root cause.
|